---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-004059"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2024-07-03T23:59:59+00:00"
generated_at: "2026-05-31T23:41:24.788883+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# VolitionRx shareholders approve 75% increase in authorized shares to 175M and new equity plan

## Summary
- Authorized shares increased from 100M to 175M (75% increase), effective July 2, 2024 via Certificate of Amendment.
- 2024 Stock Incentive Plan adopted, reserving 7.5M shares for future equity awards to employees, directors, and consultants.
- Six director nominees elected; auditor Sadler, Gibb & Associates ratified; say-on-pay advisory vote passed.
- All five stockholder proposals at annual meeting passed; 49.0M of 82.8M shares outstanding were voted.
- Both the share increase and equity plan were stockholder-approved and immediately effective.

## SEC filing metadata
- accession: 0001477932-24-004059
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2024-07-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793224004059/0001477932-24-004059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793224004059/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-004059
- JSON: https://secwatch.observer/filing/0001477932-24-004059.json
- Plain text: https://secwatch.observer/filing/0001477932-24-004059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.